Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinity

Abstract

Inhalable nanomedicines are increasingly being developed to optimise the pharmaceutical treatment of respiratory diseases. Large lipid-based nanosystems at the forefront of the inhalable nanomedicines development pipeline, though, have a number...